<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853013/" ref="ordinalpos=1820&amp;ncbi_uid=2549615&amp;link_uid=PMC2853013" image-link="/pmc/articles/PMC2853013/figure/F3/" class="imagepopup">Figure 3. VEGF <span class="highlight" style="background-color:">signaling</span> in cultured primary MNs.  From: Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. </a></div><br /><div class="p4l_captionBody">Western blotting of primary MNs treated with VEGF. (A) Time course of Akt and p44/42 MAPK phosphorylation in response to VEGF (250 ng/ml) treatment. (B) Pretreatment (1 h) with inhibitors to the PI3K/Akt pathway (LY294002; 20µM), p44/42 MAPK pathway (U0126; 20µM), and VEGFR2 (SU1948; 20µM) prevent activation of the respective signaling pathways in response to VEGF treatment.</div></div>